Second, the side effects of, for example, nausea and tachycardia have to be explained independent of central action of the drugs on GLP1 receptors inside the BBB and also cannot reflect the activation of PPG neurons
Current guidelines from the American Diabetes Association now favor GLP-1 agonists over insulin as the first injectable therapy for most patients with Type 2 diabetes
Post-op instructions may be supercharged for Ozempic patients
2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity
Their ability to regulate metabolic processes and reduce fat accumulation makes them promising candidates for treating liver diseases associated with metabolic syndrome
Consider requesting a slower dose escalation schedule to reduce gastrointestinal side effects and associated dehydration
